-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transfusion, Disease-Modifying Treatments, and Curative Therapies for Sickle Cell Disease in Africa: Where Are We Now?

Program: Education Program
Session: Challenges and Opportunities of Sickle Cell Care in Africa
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Hemoglobinopathies, Diseases, Treatment Considerations
Monday, December 9, 2024, 10:30 AM-11:45 AM

Isaac Odame, MBBCh

The Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, ON, Canada

Disclosures: Odame: Pfizer: Other: Data Safety Monitoring Board; Novo Nordisk: Honoraria; Vertex: Other: Adboard; Novartis: Research Funding.

See more of: Challenges and Opportunities of Sickle Cell Care in Africa
See more of: Education Program
<< Previous Presentation | Next Presentation >>